Møhlenberg, Michelle http://orcid.org/0000-0002-3769-4902
O’Brien, Thomas R.
Hartmann, Rune http://orcid.org/0000-0003-1159-066X
Funding for this research was provided by:
Sundhed og Sygdom, Det Frie Forskningsråd (7016-00331B)
Novo Nordisk Fonden (NNF19OC0058287)
Article History
Received: 7 February 2022
Revised: 25 April 2022
Accepted: 5 May 2022
First Online: 18 May 2022
Competing interests
: TRO’B is a coinventor on patents for the IFN-λ4 protein that are held by the National Cancer Institute. MM and RH have no competing interests to declare.